Actively Recruiting
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Led by Centre Hospitalier de Saint-Denis · Updated on 2025-09-25
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.
CONDITIONS
Official Title
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Admission to an intensive care unit (ICU) due to acute drug poisoning
- Documented exposure to either:
- Metformin alone
- Metformin in combination with dapagliflozin
You will not qualify if you...
- Patients under 18 years of age
- No exposure to metformin
- Exposure to dapagliflozin without metformin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Saint-Denis
Saint-Denis, France, France
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here